Furthermore, we determined the potential relationship between PLEKHA4 and immune cell infiltration, immune cell biomarkers, or immune checkpoints in the glioma microenvironment through the tumor immunity estimation resource (TIMER). Here, PLEKHA4 is linked to glioma.